Bone turnover markers in patients with differentiated thyroid carcinoma after levothyroxine withdrawal
Gao, Y.-C.; Gu, Q.; Liu, Q.-P.; Ge, W.-L.; Lu, H.-K.
Clinical Laboratory 56(3-4): 87-93
2010
ISSN/ISBN: 1433-6510 PMID: 20476632 Document Number: 12979
Document emailed within 1 workday
Related Documents
Gholamrezanezhad, A.; Saghari, M.; Mirpour, S.; Beiki, D.; Tarbiat, A.; Javan, S.; Abdollahzadeh, J. 2007: On-levothyroxine measurement of thyroglobulin is not a reliable test for the follow-up of patients at high risk for remnant/recurrent differentiated thyroid carcinoma Endokrynologia Polska 58(2): 100-104Bałdys-Waligórska, A.; Gołkowski, F.; Krzentowska-Korek, A.; Hubalewska-Dydejczyk, A. 2010: Radioiodine ablation of thyroid remnants in patients with differentiated thyroid carcinoma (DTC) following administration of rhTSH - a comparison with L-thyroxine withdrawal Endokrynologia Polska 61(5): 474-479
Kuroda, I.; Ueno, M. 2009: Biochemical markers of bone turnover. new aspect. Bone metabolic markers in prostatic carcinoma Clinical Calcium 19(8): 1170-1177
Sajjinanont, T.; Rajchadara, S.; Sriassawaamorn, N.; Panichkul, S. 2005: The comparative study of bone mineral density between premenopausal women receiving long term suppressive doses of levothyroxine for well-differentiated thyroid cancer with healthy premenopausal women Journal of the Medical Association of Thailand 88(Suppl 3): S71-S76
Yamauchi, M. 2009: Biochemical markers of bone turnover. new aspect. Biochemical bone markers of bone in patients treated with glucocorticoid Clinical Calcium 19(8): 1092-1100
Flynn, S.D.; Forman, B.H.; Stewart, A.F.; Kinder, B.K. 1988: Poorly differentiated ("insular") carcinoma of the thyroid gland: an aggressive subset of differentiated thyroid neoplasms Surgery 104(6): 963-970
Fu, H.; Ma, C.; Tang, L.; Wu, F.; Liu, B.; Wang, H. 2015: Recombinant human thyrotropin versus thyroid hormone withdrawal in radioiodine remnant ablation for differentiated thyroid cancer: a meta-analysis Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology and Section of the Society Of. 59(1): 121-128
Zoccali, C.; Panuccio, V.; Tripepi, G.; Cutrupi, S.; Pizzini, P.; Mallamaci, F. 2004: Leptin and biochemical markers of bone turnover in dialysis patients Journal of Nephrology 17(2): 253-260
MJ Seibel; M Koeller; B van der Velden; I Diel 2002: Long-Term Variability of Bone Turnover Markers in Patients with Non-Metastatic Breast Cancer Clinical Laboratory 48(11-12): 579-582
Grzegorzewska, A.E.; Mlot-Michalska, M. 2006: Serum markers of bone turnover in dialyzed patients grouped by level of intact parathyroid hormone Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 22: 203-206
Weckesser, M.; Schober, O. 1999: Levothyroxine for prevention of radiation-induced thyroid carcinoma in the rat Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 175(7): 349-350
Fisher, A.A.; Southcott, E.K.; Srikusalanukul, W.; Davis, M.W.; Hickman, P.E.; Potter, J.M.; Smith, P.N. 2007: Relationships between myocardial injury, all-cause mortality, vitamin D, PTH, and biochemical bone turnover markers in older patients with hip fractures Annals of Clinical and Laboratory Science 37(3): 222-232
Poungvarin, N.; Leowattana, W.; Mahanonda, N.; Bhuripanyo, K.; Pokum, S.; Worawattananon, P. 2000: Biochemical markers of bone turnover in angiographically-demonstrated coronary artery disease patients and healthy Thais Journal of the Medical Association of Thailand 83(Suppl 2): S13-S18
Cappelli, C.; Pirola, I.; Braga, M.; De Martino, E.; Morassi, M.Laura.; Gandossi, E.; Mattanza, C.; Balzano, R.; Castellano, M.; Rosei, E.Agabiti. 2006: Prognostic factors in well-differentiated thyroid carcinoma in patients treated and followed in the same institution Annali Italiani di Chirurgia 77(2): 107-113
Smit, J.W.A. 2002: The initial treatment of patients with differentiated thyroid carcinoma; consensus and controversies Nederlands Tijdschrift Voor Geneeskunde 146(10): 454-457
Smutný, S.; Vlcek, P.; Hoch, J.; Neumann, J.; Racek, P.; Nĕmec, J. 2000: The influence of a surgical intervention on the further life of patients with differentiated thyroid carcinoma Acta Universitatis Palackianae Olomucensis Facultatis Medicae 143: 101
MJ Seibel; M Koeller; B van der Velden; I Diel 2002: Markers of Bone Turnover Do Not Predict Bone Metastases in Breast Cancer Clinical Laboratory 48(11-12): 583-588
Ishikawa, T.; Sakuraba, K. 2009: Biochemical markers of bone turnover. new aspect. Bone metabolism movement in various sports and physical activities Clinical Calcium 19(8): 1125-1131
Hamada, N. 2007: Basic policy for postsurgical follow-up of patients with differentiated thyroid carcinoma--guidelines from abroad Nihon Rinsho. Japanese Journal of Clinical Medicine 65(11): 2061-2067
Markou, P.; Chatzopoulos, D. 2004: Isolation period prediction in patients with differentiated thyroid carcinoma treated after thyroidectomy by radioiodine-131 Hellenic Journal of Nuclear Medicine 7(3): 195-198